Certain food-based compounds called prebiotics may help support gut and brain health and could reduce inflammation tied to MS symptoms.
Researchers reviewed studies showing that people with brain diseases, including MS, often have fewer helpful gut microbes and weaker gut and brain barriers, which can raise inflammation. Compounds found in plants (polyphenols), specific milk proteins (bioactive peptides), and pectin breakdown products (pectin-derived oligosaccharides, or POS) can act like food for good gut bacteria. In lab and animal tests these compounds helped calm immune cells in the brain, improved cell energy centers (mitochondria), and made gut and brain barriers stronger — like fixing holes in two important fences. Early human studies suggest mood, some thinking skills, metabolism, and inflammation markers might improve, but the human evidence is limited and mixed. The gut bacteria change these compounds into active forms (for example, urolithins) that likely do much of the helpful work.
MS patients and caregivers should care because gut health changes may affect MS symptoms such as fatigue, thinking problems, and relapses; supporting gut bacteria is an extra tool alongside medicines. Think of your gut microbes as a garden: feeding the good plants (beneficial bacteria) can help the whole yard (your body) stay healthier. Caregivers and clinicians can consider diet-focused steps that include foods or supplements containing these prebiotic compounds, as part of a broader care plan. People with MS who have digestive issues, mood changes, or ongoing inflammation might see the most benefit from trying such approaches under medical supervision. This research points to realistic lifestyle steps — like choosing certain plant foods or sustainably sourced supplements — that may give small but useful improvements when combined with prescribed MS treatments.
Most positive results come from lab or animal studies, so we don’t yet know how strong the effects are in people with MS. Human trials done so far are small and use different products and measures, so results aren’t consistent yet. Always check with your neurologist or dietitian before adding supplements or making big diet changes, because some products can interact with medications or not be right for everyone.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/31/2026
Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response
Read More9/1/2026
A small study found Ma/Ma2 antibodies can cause nerve-only symptoms often linked to cancer; testing
Read More9/1/2026
Long-term study shows ravulizumab greatly reduced relapses in AQP4+ NMOSD over 3+ years with expecte
Read More9/1/2026
Even without common antibodies, NMOSD can be severe and relapsing; early maintenance immune treatmen
Read More7/20/2026
Blood levels of neurofilament light chain (NfL) often track nerve damage and treatment response in M
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Critical reviews in food science and nutrition often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.